SIGA Tech Action
ActionActionPrix
Dividendes historiques et prévisions
SIGA Tech a jusqu'à présent distribué 0,60 $US en 2024. Le prochain dividende sera payé le 11.04.2025
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de SIGA Tech ?
Quel est le ratio cours/bénéfice (P/E) de SIGA Tech ?
Quel est le bénéfice par action (BPA) de SIGA Tech ?
Quel est le chiffre d'affaires de SIGA Tech sur les douze derniers mois ?
Quel est l'EBITDA de SIGA Tech ?
Quel est le flux de trésorerie disponible de SIGA Tech ?
Quel est le bêta à 5 ans de l'action SIGA Tech ?
Combien d'employés compte SIGA Tech, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de SIGA Tech ?
Finances
Capitalisation boursière
538,12 M $USbêta sur 5 ans
0,91BPA (TTM)
1,162 $USFree Float
40,51 MRatio P/E (TTM)
6,49Recettes (TTM)
172,96 M $USEBITDA (TTM)
103,38 M $USCash-flow disponible (TTM)
73,77 M $USCotation
Informations
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks, vaccines and therapies for emerging infectious diseases, and health preparedness. The Company's lead product is TPOXX, also known as tecovirimat and ST-246, an orally administered and intravenous (IV) formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the United States maintains a supply of TPOXX under Project BioShield. The European Medicines Agency and United Kingdom approvals include labeling for oral tecovirimat indicating its use for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications following vaccination against smallpox. It uses third parties known as contract manufacturing organizations to procure commercial raw materials and supplies, and to manufacture TPOXX.
45
Biotechnology & Drugs
Soins de santé
Identifiant
ISIN
Ticker primaire